Drug Product
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
FRIULCHEM S.P.A is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Italy
Founded:1993
Employees:556
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Global
Regulatory Approvals
Drug Approval N2A1DX
EMA · #APR-CDOAZZAG · 2022-07-01
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-857SYMF2
Issued: 2020-01-05
Expires: 2025-09-21
WHO GMP
World Health Organization
Cert #: CERT-8S83J0K3
Issued: 2020-10-16
Expires: 2025-10-13
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-POVJK4XG
Issued: 2020-11-02
Expires: 2025-03-15
Loading CDMO intelligence...
Key facts about FRIULCHEM S.P.A
- FRIULCHEM S.P.A is headquartered in Italy.
- FRIULCHEM S.P.A was founded in 1993.
- FRIULCHEM S.P.A has 556 employees.
- FRIULCHEM S.P.A's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like FRIULCHEM S.P.A
Directory pages this company appears in, each with the full list of matching manufacturers.